SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Agouron Pharmaceuticals (AGPH)
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: mumbles who wrote (5194)8/19/1998 8:42:00 PM
From: JimieA   of 6136
 
I also was suspicious that Hoffman LaRoche's termination of their collaboration on AGPH's cancer drugs reduced the appeal of those drugs as potential blockbuster drugs. And therefore has reduced the appeal of AGPH as an investment.

Although this has been reflected in AGPH's steady price decline since the beginning of the year. That along with the PI bad press at the recent AIDS conference has pushed the stock price down.

But, I could be wrong.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News